A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1862-8354|12|1|prca.201700131-prca.201700131

ISSN： 1862-8346

Source： PROTEOMICS - CLINICAL APPLICATIONS, Vol.12, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics

By Liu Yahui   Qing Hong   Deng Yulin  

International Journal of Molecular Sciences, Vol. 15, Iss. 5, 2014-05 ,pp. : 7865-7882

MDPI

Access to resources Recommend Favorite

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF

By  

PROTEOMICS - CLINICAL APPLICATIONS, Vol. 9, Iss. 7-8, 2015-08 ,pp. : 715-731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

By Kosicek Marko   Hecimovic Silva  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 1310-1322

MDPI

Access to resources Recommend Favorite

Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 360-4012, Iss. 11, 2015-11 ,pp. : 1664-1674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry

By Rauniyar Navin  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 28566-28581

MDPI

Access to resources Recommend Favorite